Cetuximab or nimotuzumab in combination with chemotherapy for treating recurrent/metastatic nasopharyngeal carcinoma: A meta‑analysis and systemic review

The present study aimed to evaluate the effectiveness and safety of cetuximab (CTX) or nimotuzumab (NTZ) in combination with chemotherapy for patients with recurrent and/or metastatic nasopharyngeal carcinoma (RM-NPC), and for this purpose, a single-group rate meta-analysis was performed. A systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Xiaoling, Zhang, Junqi, Zhu, De, Du, Qing, Yang, Jun, Yue, Hong Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131271/
https://www.ncbi.nlm.nih.gov/pubmed/37123019
http://dx.doi.org/10.3892/ol.2023.13790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131271/
https://www.ncbi.nlm.nih.gov/pubmed/37123019
http://dx.doi.org/10.3892/ol.2023.13790

Ejemplares similares